|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 305, Issue 2, 680-687, May 2003
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
| |
Abstract |
|---|
|
|
|---|
To understand the role of
N-methyl-D-aspartate (NMDA) receptors in the
prefrontal cortex (PFC) and to investigate how the psychotomimetic drug
phencyclidine (PCP) may alter PFC function, we made whole-cell
recordings from PFC neurons in rat brain slices. Our result showed that
most deep layer pyramidal neurons in the PFC were regular spiking
cells. They could fire repetitive bursts, however, when activated by
glutamate focally applied to the apical dendrite. Application of NMDA
to the same dendritic spot also induced bursting, whereas application
of
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) evoked
single spikes only. Coapplication of AMPA with NMDA evoked more single
spikes and decreased NMDA-induced bursting. Experiments with NMDA and
AMPA antagonists further showed that dendritic glutamate (dGlu)-induced
bursting required NMDA receptor activation and was enhanced when AMPA
receptors were blocked. At subanesthetic concentrations, PCP decreased
dGlu-induced bursting and altered the temporal characteristics of the
bursts by decreasing spikes per burst and increasing interspike
intervals within bursts. The latter two changes were not observed when
AMPA receptors were blocked, suggesting that they are secondary to the
increased AMPA receptor contribution to glutamate responses evoked in
the presence of PCP. These results suggest that NMDA receptors are
essential for PFC pyramidal cells to fire in bursts in response to dGlu input and that PCP suppresses dGlu-induced bursting. Since bursting is
necessary for pyramidal cells to activate GABA interneurons, the
suppression effect of PCP may further lead to a weakening of the
connections from pyramidal cells and GABA interneurons, thereby
contributing to PCP's psychotomimetic effects.
| |
Introduction |
|---|
|
|
|---|
Cortical
pyramidal neurons are traditionally grouped into two categories:
regular spiking and intrinsic bursting cells. When activated by a
sustained depolarization induced by intrasomatic current injection,
regular spiking cells fire repetitive single spikes or an initial
doublet followed by single spikes. Intrinsic bursting cells, on the
other hand, fire repetitive bursts. The two types of cells also differ
morphologically (Chagnac-Amitai et al., 1990
; Mainen and
Sejnowski, 1996
). Although fewer than regular spiking cells, intrinsic
bursting neurons are present in most cortical areas examined and have
been suggested to play an important role in synchronized activities in
the cortex (Chagnac-Amitai and Connors, 1989
).
In a preliminary study, we reported that regular spiking neurons in the
prefrontal cortex (PFC) could fire repetitive bursts when they were
activated by glutamate focally applied to the apical dendrite (Zhang
and Shi, 1999
). Dendritic glutamate (dGlu)-induced bursting has also
been reported in the sensorimotor cortex (Schwindt and Crill, 1997
).
Studies in the latter area further suggest that the activity is
triggered by activation of voltage-gated Ca2+
channels due to dendritic depolarization (Schwindt and Crill, 1999
). In
the PFC, however, we found that NMDA but not AMPA mimicked dGlu-induced
bursting (Zhang and Shi, 1999
), suggesting that the mechanism
underlying dGlu-induced bursting in the PFC may differ from that
observed in the sensorimotor cortex, depending upon activation of NMDA receptors.
In the present study, experiments were carried out to further test whether dGlu-induced bursting in the PFC is simply due to a dendritic depolarization or whether it requires activation of NMDA receptors. Since both NMDA and non-NMDA receptors are activated by glutamate, this study also asked whether, and how, non-NMDA receptors, especially AMPA receptors, may contribute to dGlu-induced bursting. Finally, we examined the effects of the psychotomimetic drug phencyclidine (PCP) on dGlu-induced bursting because 1) PCP is a potent NMDA receptor channel blocker, 2) PCP is thought to produce part of its psychotomimetic effects by affecting PFC function, and 3) changes in bursting would significantly alter information processing in the PFC, thereby contributing to PCP's psychotomimetic effects.
| |
Materials and Methods |
|---|
|
|
|---|
Preparation of Slices.
All procedures were performed in
accordance with those outlined in the Guide for the Care and Use
of Laboratory Animals published by the U.S. Public Health Service
and approved by the Yale Animal Care and Use Committee. Male
Sprague-Dawley albino rats weighing between 33 and 104 g (2-5
weeks old; Charles River Laboratories, Inc., Wilmington, MA) were used.
Brain slices were prepared as described previously (Shi et al., 1997
;
Zheng et al., 1999
). Briefly, rats were anesthetized with chloral
hydrate (400 mg/kg i.p.) and decapitated. The brains were quickly
dissected and submerged in an ice-cold perfusion medium containing 125 mM NaCl, 3 mM KCl, 1.4 mM MgSO4, 1.2 mM
CaCl2, 1.2 mM
NaH2PO4, 25 mM
NaHCO3, 10 mM glucose, 10 mM sucrose, and
saturated with 95% O2/5%
CO2. A block of tissue containing the PFC was cut
and glued on the cutting stage of a Vibratome (OTS-4000 tissue slicer;
FHC Inc., Bowdoinham, ME). Serial coronal slices (280-300 µm) were
cut and transferred to an incubating chamber where they were held at
35°C for at least 1 h before recording.
Electrophysiological Recording.
During recording, slices
were continuously perfused at room temperature in a submerged recording
chamber placed on the fixed stage of an upright microscope (BX50WI;
Olympus Optical Co. Ltd., Tokyo, Japan). Individual neurons were
visualized using Nomarski optics and a 40× long working distance,
water immersion objective (3 mm, NA 0.7; Olympus). The image was
enhanced with an infrared-sensitive CCD camera (CCD-300T-RC; Dage-MTI,
Michigan City, IN; infrared blocking filter removed) and displayed on a
video monitor. Pyramidal cells were identified based on their pyramidal
shape and the presence of the apical dendrite. Whole-cell recordings
were made from the soma using electrodes pulled from thin-walled glass
capillaries (o.d. = 1.5 mm; WPI, Sarasota, FL). Electrodes were
filled with a solution containing 140 mM potassium gluconate,
0.1 mM CaCl2, 2 mM MgSO4, 1 mM EGTA, 2 mM ATPK2, 0.1 mM
GTPNa3, 10 mM HEPES, and 0.5% biocytin, pH 7.25, and had a resistance of 7 to 12 M
. Voltage and current signals were
recorded with an Axoclamp-2A (Axon Instruments, Inc., Union
City, CA) interfaced to a personal computer (Dimension XPS Pro200n;
Dell, Austin, TX). Data were digitized (Digidata 1200; Axon) and stored
on disks using jClamp (v.3.4; J. Santos-Sacchi, Yale University) or
pClamp (V8; Axon). Off-line data analysis was performed using pClamp
and Visual Basic Macros in Microsoft Excel. All potentials reported
were with a correction for junction potential (15 mV) between the
electrode and the perfusion medium, which was calculated based on ionic compositions of the intra- and extracellular solutions using pClamp. A
similar junction potential was reported by previous studies using
similar solutions (e.g., Neher, 1992
).
Drug Application. Glutamate and its agonists were applied focally to the apical dendrite (50-150 µm away from the soma) using multibarrel micro-iontophoretic electrodes. The tip of the electrode was 2 to 3 µm in diameter. One barrel was filled with 0.5 M NaCl and used as the balance electrode. Current through the balance electrode was automatically adjusted so that the sum of currents through all barrels equaled zero. Other barrels were filled with solutions containing glutamate (100 mM, pH 8.5), NMDA (100 mM, pH 8.5), and AMPA (100 mM, pH 8.5), respectively. A positive retaining current (10 nA) was applied to all drug barrels to eliminate passive diffusion when the drug was not ejected. All drugs were ejected with negative currents ranging from 0 to 50 nA. In some experiments, glutamate and its agonists (50-100 µM) were applied using pressure ejection (5-40 psi for 10-20 ms at 15-40 pulses/s). The pipette used for pressure ejection had the same characteristics as the pipette used for recording. Increasing amounts of glutamate were applied by increasing the frequency of the ejection (pulses per second). Results obtained with the two application methods were similar and were, therefore, analyzed together. All other drugs were administered through the bath via a three-way stopcock.
Drugs used in this study and their sources are glutamate (Sigma-Aldrich, St. Louis, MO); NMDA, AMPA, NBQX, phencyclidine, and ketamine (Sigma/RBI, Natick, MA); CGP37849 (Ciba Specialty Chemicals, Basel, Switzerland); and tetrodotoxin (TTX; Alomone Labs Ltd., Jerusalem, Israel).Biocytin Staining. At the end of recording, slices were fixed overnight with 4% paraformaldehyde in phosphate buffer solution (pH 7.4) and then washed and transferred to phosphate buffer solution containing 0.5% Triton X-100 and 1% hydrogen peroxide for 3 h. After rinsing, slices were incubated with avidin-biotinylated peroxidase complex (Vectstain Elite ABC kits PK-6100; Vector Laboratories Inc., Burlingame, CA) in the presence of 0.5% Triton X-100 for 36 h. The peroxidase was visualized by reacting the slice with diaminobenzidine and hydrogen peroxide.
Statistics. The statistical significance of a drug effect on dGlu-induced bursting was determined by comparing dGlu-induced bursting before and after the drug application using analysis of covariance. The covariate was the response of the cell prior to drug perfusion. All numerical data were expressed as mean ± S.E.M.
| |
Results |
|---|
|
|
|---|
Firing Properties of PFC Pyramidal Cells.
Data presented in
this study were obtained from 280 PFC neurons; all were visually
identified as pyramidal cells using infrared videomicroscopy (see
Materials and Methods). After biocytin staining, 181 cells
were recovered, and all were confirmed to be pyramidal cells. An
example of an intracellularly stained pyramidal cell is shown in Fig.
1A. Most labeled cells were located in
layers V and VI of the prelimbic subdivision of the PFC (Fig. 1B). Some were found in the adjacent infralimbic cortex. No difference was observed between the results obtained from the two areas.
|
71 to
83 mV (
76.6 ± 0.2 mV; n = 242). When
depolarized by intrasomatic current steps (20-450 pA for 1500 or 3500 ms), all exhibited repetitive firing. Most cells showed an initial doublet (n = 164) or a triplet (n = 2)
followed by single spikes (Fig. 2A). The
remaining cells (n = 53) fired repetitive single spikes
only. Repetitive bursting was not observed in any of the cells
examined.
|
76.6 ± 0.2 mV; n = 242). These results suggest that the PFC
differs from other cortical areas and lacks intrinsic bursting cells.
dGlu-Induced Bursting.
In a preliminary study (Zhang and Shi,
1999
), we showed that dGlu could evoke repetitive bursting in PFC
pyramidal cells. To confirm the finding, glutamate was focally applied
to the apical dendrite in 122 PFC pyramidal cells. Of these cells, 78 exhibited repetitive bursting and 44 showed regular spiking. However,
when cells of the latter group were hyperpolarized (2-20 mV from the resting potential), all showed repetitive bursting in response to dGlu
application (n = 34). The minimum hyperpolarization
required for bursting was not systemically determined because it varied from cell to cell and depended on both the amount and the site of
glutamate application. The latter may reflect the fact that glutamate
receptors are unevenly distributed on the apical dendrite (Dodt et al.,
1998
).
|
Effects of NMDA and AMPA.
To study the role of NMDA and AMPA
receptors in dGlu-induced bursting, we have previously compared effects
of glutamate, NMDA, and AMPA (Zhang and Shi, 1999
). The comparison was
made, however, between cells. In this study, we compared the three
agonists in the same cell by applying them to the same dendritic sites
using multibarrel iontophoretic electrodes. Such comparison minimizes possible variance due to differences between cells and drug application sites. In all cells studied (n = 7), the three agonists
depolarized the cell and induced firing. However, unlike glutamate and
NMDA, both of which induced repetitive bursting (Fig.
4, A and B), AMPA induced single spikes
only (Fig. 4C).
|
0.001). The average ISI1 was
28.8 ± 8.2 ms for glutamate-induced bursts and 15.4 ± 3.1 ms for NMDA-induced bursts (F1,11 = 9.02, p < 0.05). These differences suggest that activation
of non-NMDA receptor by glutamate may attenuate glutamate's ability to
induce bursting through NMDA receptors.
NMDA-AMPA Interaction.
To more directly test whether
coactivation of AMPA receptors decreases the ability of NMDA to induce
bursting, AMPA was coapplied with NMDA using multibarrel electrodes. In
all 12 cells tested, coadministration of AMPA increased single spikes
and decreased bursting induced by NMDA (Fig.
5), resulting in a firing pattern similar
to that induced by glutamate. On average, AMPA application decreased
spikes per burst induced by NMDA from 5.9 ± 1.3 to 2.6 ± 0.4 and increased ISI1 from 19.5 ± 1.7 to
40.7 ± 5.5 ms (n = 12). Both effects were
statistically significant (spikes per burst: F1,21 = 18.89, p < 0.001;
ISI1: F1,21 = 29.66, p < 0.001).
|
Effects of NMDA and AMPA Antagonists.
To confirm further that
dGlu-induced bursting requires activation of NMDA receptors, glutamate
was applied in the presence of the competitive NMDA antagonist CGP37849
or the AMPA antagonist NBQX. As might be expected, dGlu induced single
spikes only when NMDA receptors were blocked by CGP37849 (1-10 µM,
n = 6; Fig. 6A). However,
it reliably induced bursting when AMPA receptors were blocked by NBQX
(5-10 µM, n = 4; Fig. 6B).
|
Effects of Synaptic Blockade.
Our previous study suggests that
dGlu-induced bursting is a direct effect of glutamate on the recorded
cell because displacement of the iontophoretic electrode a few
micrometers away from the apical dendrite resulted in an abrupt
reduction in the response of the cell (Zhang and Shi, 1999
). To further
confirm this suggestion and to reduce possible polysynaptic effects
mediated through glutamate and GABA neurons, NMDA was applied to
selectively activate NMDA receptors, whereas AMPA and
GABAA receptors were blocked by NBQX (5 µM) and
picrotoxin (30 µM), respectively. In all 12 cells tested, dendritic
NMDA application reliably induced bursting.
|
Effects of PCP.
PCP is an NMDA receptor channel blocker.
Compared with CGP37849, PCP (1-5 µM) was less effective in
inhibiting dGlu-induced bursting. In four of seven cells, CGP37849
(1-10 µM) transformed dGlu-induced bursting into single-spike firing
(Fig. 4A). In the three remaining cells, CGP37849 decreased the number
of bursts and then completely stopped firing. PCP also decreased the
number of bursts but failed to completely convert bursting into
single-spike firing. Bursts induced in the presence of PCP differed,
however, from those observed under control conditions; spikes per burst were decreased, whereas within-burst ISIs were increased (Fig. 8A). Unexpectedly, a high concentration
of PCP (10 µM) decreased the number of bursts without affecting
spikes per burst and within-burst ISIs (n = 5; Fig.
9). At this concentration, PCP also
produced a hyperpolarization of the cell (4.9 ± 0.7 mV,
n = 5).
|
|
Effects of Ketamine.
Ketamine is also an NMDA receptor channel
blocker and a psychotomimetic drug. In all cells tested, ketamine
(10-100 µM, n = 6) decreased the number of bursts
induced by dGlu and spikes per burst (from 2.8 ± 0.3 to 2.2 ± 0.2, F1,9 = 5.77, p < 0.05) and increased within-burst ISIs (from 18.8 ± 1.9 to 32.2 ± 5.9, F1,9 = 8.12, p < 0.05; Fig.
8B). Unlike PCP, however, ketamine had no effect on the resting
membrane potential. This finding and the fact that CGP37849 also had no
effect on the resting membrane potential suggest that the
hyperpolarization induced by the high concentration of PCP is mediated
through sites unrelated to NMDA receptors (Johnson and Jones, 1990
).
Role of AMPA Receptors in Effects of PCP.
Proportionally, a
glutamate response evoked in the presence of PCP would contain more
AMPA component than it does under control conditions. Since AMPA
receptor activation is detrimental to burst generation (see results
above), some effects of PCP may be secondary to the increased AMPA
contribution to glutamate responses in the presence of PCP. To test
this possibility and to avoid activation of AMPA receptors, NMDA or
glutamate was applied while AMPA receptors were blocked by NBQX (3-10
µM). Under such conditions, PCP (1-5 µM) decreased the number of
bursts without an effect on spikes per burst (from 3.1 ± 0.4 to
3.3 ± 0.4, F1,11 = 0.31, p = 0.58, Fig. 10A) and within-burst ISIs
(ISI1 from 29 ± 8 to 28 ± 10, F1,11 = 0.63, p = 0.81).
|
| |
Discussion |
|---|
|
|
|---|
This study shows that most deep-layer pyramidal cells in the PFC fire single spikes or an initial doublet followed by single spikes in response to somatic depolarization. The same cells fire repetitive bursts when activated by glutamate applied to the apical dendrite. dGlu-induced bursting requires NMDA receptor activation and is attenuated when AMPA receptors are coactivated. Activation of AMPA receptors favors single-spike firing. The psychotomimetic drug PCP decreases dGlu-induced bursting and alters the temporal characteristics of the bursts. The latter effect is not observed when AMPA receptors are blocked, suggesting that it is secondary to the increased AMPA contribution to a glutamate-evoked response in the presence of PCP.
Lack of Intrinsic Bursting Cells in the PFC.
Cortical
pyramidal neurons are traditionally grouped into two categories:
regular spiking and intrinsic bursting cells (see the introduction).
The present study suggests that the PFC differs from most other
cortical areas and lacks intrinsic bursting cells, cells that are
capable of firing repetitive bursts upon somatic depolarization. This
finding is unlikely to be an artifact of recording since, using the
same techniques, we were able to find intrinsic bursting cells in the
somatosensory cortex. Furthermore, using traditional intracellular
recording techniques, several groups also reported a lack of intrinsic
bursting cells in the PFC (Penit-Soria et al., 1987
; Foehring et al.,
1991
; de la Pena and Geijo-Barrientos, 1996
; Haj-Dahmane and Andrade,
1996
; Henze et al., 2000
). In one study, however, repetitive bursting
was observed in 13% of PFC pyramidal cells (Yang et al., 1996
). The cause for the difference is unknown. Although it remains to be confirmed, the lack of intrinsic bursting cells would suggest that
bursting activities in the PFC are more dependent on dendritic glutamate input and, thus, more susceptible to the suppression effect
of PCP compared with other cortical areas.
dGlu-Induced Bursting Requires Activation of NMDA Receptors.
This study confirms our previous results (Zhang and Shi, 1999
), showing
that PFC cells could fire repetitive bursts when activated by glutamate
applied to the apical dendrite. dGlu-induced bursting has been reported
previously in the sensorimotor cortex (Schwindt and Crill, 1997
) and
has been suggested to be mediated by a dendritic depolarization and
subsequent activation of voltage-gated Ca2+
channels (Schwindt and Crill, 1999
). Supporting this suggestion, direct
intradendritic current injection evokes or promotes burst firing in
hippocampal pyramidal cells (Wong and Stewart, 1992
).
dGlu-Induced Bursting Is a Direct Effect of Glutamate on the
Recorded Cell.
Several lines of evidence suggest that dGlu-induced
bursting is a direct effect of glutamate on the recorded cell. As shown previously, displacement of the iontophoretic electrode a few micrometers away from the apical dendrite resulted in an abrupt reduction in the response (Zhang and Shi, 1999
). This study further showed that dGlu-induced bursting persisted in the presence of the
GABAA antagonist picrotoxin, suggesting that GABA
interneurons are unlikely to be involved. Blockade of synaptic
transmissions by Cd2+ or TTX also failed to
prevent dGlu from inducing bursting or membrane oscillations.
Effects of PCP.
Both PCP and ketamine induced a partial
inhibition of dGlu-induced bursting. Given the concentrations used, the
result seems to contradict the reported affinities of PCP and ketamine
to NMDA receptors (e.g., Bresink et al., 1995
). One possible
explanation is that the affinities were measured in the absence of
Mg2+, whereas the present study was performed in
the presence of Mg2+. Physiological
concentrations of Mg2+ are known to decrease the
ability of PCP to block NMDA receptor channels (e.g., Lerma et al.,
1991
).
Role of AMPA Receptors in dGlu-Induced Bursting and in the Effects of PCP. Although dGlu-induced bursting does not require AMPA receptor activation, this study suggests that AMPA receptors play an important modulatory role in the activity. Several lines of evidence suggest that activation of AMPA receptors favors single-spike firing and decreases the bursting mediated by NMDA receptors. Thus, unlike NMDA, which evoked bursts only, glutamate often induced a mixture of bursts and single spikes. When AMPA receptors were blocked, however, glutamate induced bursts only, suggesting that AMPA receptor activation is responsible for the generation of single spikes. Further supporting this suggestion, coapplication of AMPA with NMDA reduced NMDA-induced bursting and, at the same time, increased single-spike firing.
AMPA receptors may also play a role in PCP-induced changes in spikes per burst and within-burst ISIs. This study showed that when AMPA receptors were blocked, PCP produced no effects on the two measurements. This result, together with the finding that AMPA receptor coactivation decreases NMDA-induced bursting, suggests that changes in spikes per burst and within-burst ISIs induced by PCP are secondary to the increased AMPA receptor contribution to glutamate responses evoked in the presence of PCP. The modulatory role of AMPA receptors may provide part of the explanation for why an AMPA antagonist can reverse some of the behavioral effects induced by PCP (Moghaddam and Adams, 1998| |
Acknowledgments |
|---|
We thank Dr. B. S. Bunney for suggestions and comments and C.-L. Pun for technical assistance.
| |
Footnotes |
|---|
Accepted for publication January 9, 2003.
Received for publication October 31, 2002.
This work was supported by U.S. Public Health Service Grants MH52686 and DA12944, and a National Alliance for Research on Schizophrenia and Depression Young Investigator Award to W.-X.S.
DOI: 10.1124/jpet.102.046359
Address correspondence to: Dr. Wei-Xing Shi, Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511. E-mail: wei-xing.shi{at}yale.edu
| |
Abbreviations |
|---|
PFC, prefrontal cortex;
dGlu, dendritic
glutamate;
NMDA, N-methyl-D-aspartate;
AMPA,
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;
PCP, phencyclidine;
CCD, charge-coupled device;
NBQX, 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline;
CGP37849, (E)-(±)-2-amino-4-methyl-5-phosphono-3-pentenoic acid;
TTX, tetrodotoxin;
ISI, interspike interval.
| |
References |
|---|
|
|
|---|
indication of NMDA receptor heterogeneity.
Neuropharmacology
34:
533-540[CrossRef][Medline].This article has been cited by other articles:
![]() |
A. Burgos-Robles, I. Vidal-Gonzalez, and G. J. Quirk Sustained Conditioned Responses in Prelimbic Prefrontal Neurons Are Correlated with Fear Expression and Extinction Failure J. Neurosci., July 1, 2009; 29(26): 8474 - 8482. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kargieman, N. Santana, G. Mengod, P. Celada, and F. Artigas Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine PNAS, September 11, 2007; 104(37): 14843 - 14848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Large Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? J Psychopharmacol, May 1, 2007; 21(3): 283 - 301. [Abstract] [PDF] |
||||
![]() |
W.-X. Shi Slow Oscillatory Firing: A Major Firing Pattern of Dopamine Neurons in the Ventral Tegmental Area J Neurophysiol, November 1, 2005; 94(5): 3516 - 3522. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Homayoun, M. E. Jackson, and B. Moghaddam Activation of Metabotropic Glutamate 2/3 Receptors Reverses the Effects of NMDA Receptor Hypofunction on Prefrontal Cortex Unit Activity in Awake Rats J Neurophysiol, April 1, 2005; 93(4): 1989 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Jackson, H. Homayoun, and B. Moghaddam NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex PNAS, June 1, 2004; 101(22): 8467 - 8472. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||